Cell therapy could help unlock checkpoint inhibitors’ potential in solid tumors, but combination regimens raise the bar for manufacturing consistency and scalability.
- The Decision Rights Matrix: Making Sponsor-CDMO Governance Enforceable
- Defining Quality In A Sponsor-Owned QTPP Before The CDMO Even Starts
- ImvivaBio's Trial For Off-The-Shelf CAR-T Strategy For Aggressive Malignancies
- Reshoring Pressure Meets Manufacturing Reality
- CDMO Live Europe 2026: Partnerships For An Uncertain World
- Resilience, Risk, And Relationships: CDMO Live Europe 2026 Report
- Demonstrating Non-Inferiority Of BFPCs Vs. Traditional Air Monitoring
- Pharmacogenomics In Oncology: A Pharmacokinetic Perspective
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![SUS - Image_Case_study_automating_450x300]( "Automating The Process Of Filling Media Into Bottles")
Automating The Process Of Filling Media Into BottlesLearn how a vaccine manufacturer using a wide range of containers for media and buffer filling was able to increase efficiency by 70% with an automated closed-system solution.
-
![GettyImages-500323894 research tech]( "Advances In Flow-Through Technology To Enhance mAb Polishing")
Advances In Flow-Through Technology To Enhance mAb PolishingOptimize your monoclonal antibody purification with cutting-edge flow-through chromatography. Learn how POROS resins enhance polishing efficiency, improve aggregate removal, and streamline bioprocessing.
-
![GettyImages-1181392775 lab, research]( "Navigating The Cell And Gene Regulatory Landscape")
Navigating The Cell And Gene Regulatory LandscapeNavigating the complex regulatory landscape is essential for cell and gene therapy success. Explore key considerations, challenges, and best practices for companies operating in this space.
-
![GettyImages-1285104827-assay-plate-imaging-analysis]( "Fully Automated Cell Culture Passaging And Expansion")
Fully Automated Cell Culture Passaging And ExpansionAutomating cell culture tasks can reduce human error and free scientists from labor-intensive routines. Discover how imaging and automated systems enhance accuracy and reproducibility in cell culture processes.
-
![Thermo- HoodLab3Scientists]( "Achieving Titer Increase Up To 4-Fold While Maintaining Product Quality")
Achieving Titer Increase Up To 4-Fold While Maintaining Product QualityDiscover customizable solutions for antibody manufacturing, as well as services for media optimization, feeding strategy optimization, and format conversion.
-
![GettyImages-1871216402-anaerobic-cultivation-of-probiotics]( "Anaerobic Cultivation Processes Of Probiotic Bacteria")
Anaerobic Cultivation Processes Of Probiotic BacteriaCultivate oxygen-sensitive probiotics with precision using real-time monitoring, microfluidic feeding, and pH control for reproducible growth and optimized microbiome and fermentation research.
-
![GettyImages-597972428-adenovirus]( "Development Strategies For Adenovirus-Based Gene Therapies")
Development Strategies For Adenovirus-Based Gene TherapiesScaling up viral vector production can be challenging, and ensuring consistent titers and activity requires careful optimization and technical expertise.
-
![GettyImages-2189362114-recombinant-protein-structure]( "Comparing Process Development Approaches For Recombinant Proteins")
Comparing Process Development Approaches For Recombinant ProteinsExplore how adding a traceless tag enables streamlined affinity purification for recombinant proteins, and how this approach compares with a conventional process in development time, recovery, and purity.
-
![Scientist Using Tablet In Lab GettyImages-1354172577]( "384-Well Microplate Time Resolved Fluorescence (TRF) Immunoassay")
384-Well Microplate Time Resolved Fluorescence (TRF) ImmunoassayExamine how innovative sandwich ELISAs in a 384-well format can be utilized with a sensitive reader for high-throughput screening to quantify Human IgG and IFN gamma.
-
![Bladder and Kidneys-GettyImages-1339092350]( "Tailored Approach Supports Bladder Cancer Breakthrough")
Tailored Approach Supports Bladder Cancer BreakthroughDiscover how a flexible operational strategy and expert site management help bladder cancer programs overcome complex logistical hurdles and achieve critical regulatory milestones.
NEWSLETTER ARCHIVE
- 08.06.26 -- The CDMO Perspective On Breaking Down Development Silos In Vivo CGT
- 08.05.26 -- Advancing Precision In Clinical Trial Design
- 08.05.26 -- How Precision Oncology Is Redefining Cancer Drug Development With Aprea Therapeutics' Dr. Oren Gilad
- 08.04.26 -- De-Risk MSC Development From Source To Scale
- 08.04.26 -- STREAM Edition: When Great Biology Meets Manufacturing Reality
- Solving Vector Yield Challenges Starts Long Before Manufacturing
- Full FDA Approval For TECELRA Marks More Than A Regulatory Win For Solid Tumors
- FDA Approval Of TREGZI Signals A New Era For Precision Engineered Cell Therapy
- How CGT Developers Should Think About Manufacturing Models, Hybrid Strategies, And Scale
- In Vivo Gene Editing Is Moving From Promise To Proof
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections
